Shield Bio
Shield Bio is a YC Summer 2016 (S16) company. Based in San Jose, CA, USA. Team of 28.
About Shield Bio
Summary
Shield Bio builds a proprietary nanopore sequencing platform that produces results in under a minute at the point of care, replacing slower laboratory sequencing workflows that delay clinical decisions. The platform is designed for clinical settings and targets precision medicine, starting with infectious disease and sepsis, where rapid pathogen identification directly shapes treatment.
From the Y Combinator listing
Bringing 3rd generation, nanopore sequencing to healthcare to solve…
Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.
Facts
- Healthcare / Healthcare -> Diagnostics
- San Jose, CA, USA
- 28
- Inactive
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works